AstraZeneca Inks R&D Deal With Ramaswamy's Roivant for Hush-Hush Indication
Vivek Ramaswamy's parent company, Roivant Sciences, inked a development deal with Astra. Source: BioSpace
Pfizer Gets Incentives to Keep a 250 Employee Workforce in Memphis
About 250 Pfizer employees will remain in the Memphis area after the pharma giant secured a partial tax freeze for 14 years from local governments that will save the company…
Eli Lilly Looks Over Its Shoulder After Novo Nordisk Wins FDA Panel Backing for Diabetes Drug
An advisory panel with the FDA gave a near unanimous support to Novo Nordisk's diabetes drug semaglutide, a long-acting GLP-1 analogue. Source: BioSpace
uniQure Researchers Swap Out Lead Drug for a Better Prospect
The company plans to expeditiously advance AMT-061 instead of AMT-060. Source: BioSpace
FDA Approves Second Gene Therapy
The FDA approved a second gene therapy for cancer, adding Kite Pharma’s lymphoma treatment Yescarta (axicabtagene ciloleucel) to the fledgling list. Source: Drug Industry Daily
FDA Blows the Whistle on UMich for Unsterile Conduct
The University of Michigan Medical Center processed and compounded drugs under unsanitary conditions, the FDA said in a warning letter. Source: Drug Industry Daily
Court Levies $40 Million Judgement Over Deceptive Weight-Loss Claims in FTC Case
An Atlanta federal judge found several individuals and their two firms in contempt for violating court orders over the sale of deceptively marketed weight-loss supplements, imposing a judgement of more…
McCaskill Introduces Bill to Repeal Law that Weakened DEA Authority Over Opioids
Sen. Claire McCaskill (D-Mo.) introduced a bill that would repeal 2016 legislation that she believes weakened the Drug Enforcement Administration’s ability to go after opioid distributors. Source: Drug Industry Daily
FDA Advisory Committee Votes in Favor of Novo Nordisk’s Diabetes Injectable
An FDA advisory committee voted Wednesday to recommend that the FDA approve semaglutide, Novo Nordisk’s drug candidate for Type 2 diabetes. Source: Drug Industry Daily
FDA Flags Vital Laboratories for Inadequate Storage, Training
The FDA cited a Vital Laboratories facility in Gujarat, India over failure to investigate out of specification results, conditions for material storage, and employee training. Source: Drug Industry Daily
- Go to the previous page
- 1
- …
- 284
- 285
- 286
- 287
- 288
- 289
- 290
- …
- 610
- Go to the next page